- Abstract
- Keywords
- Introduction
- Chemistry of BD
- Antineoplastic effects of BD in human malignancies
- Anti-metastatic effects of BD
- Potential anti-inflammatory effects of BD
- Pharmacokinetics, toxicity and metabolism
- Clinical application of BD
- Conclusion and future directions
- Abbreviations
- Declarations
- References
-
Citing Article List
The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Extra-hepatic cancers in metabolic fatty liver syndromes”.No. Publication Date Citing Article 1 2023 Amedeo Lonardo, Principles of risk stratification in nonalcoholic fatty liver disease. A narrative review emphasizing non-invasive strategies, Exploration of Digestive Diseases. 2023; 188. https://doi.org/10.37349/edd.2023.00026 2 2023 Amedeo Lonardo, Iron depletion in “metabolic fatty liver syndromes”: a strong biological rationale with disappointing liver outcomes, Exploration of Drug Science. 2023; 239. https://doi.org/10.37349/eds.2023.00016 3 2023 Amedeo Lonardo, MASLD co-aggregates with HCC in families-names change, fa(c)ts remain, Hepatoma Research. 2023; https://doi.org/10.20517/2394-5079.2023.110 -
